APO Research
Talk to an analyst

APO RESEARCH · REPORT

Biological Indicators

Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.

Selected research

Market Analysis & Forecast

Global Biological Indicators Market Analysis and Forecast 2026-2032

21 December 2025191 pages

Choose your research edition.

Industry ResearchBiological Indicators Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Biological Indicators Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Biological Indicators Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Biological Indicators Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Biological Indicators Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Biological indicators (BIs), as defined by ANSI/AAMI and ISO, are test systems containing viable microorganisms providing a defined resistance to a specific sterilization process. A biological indicator provides information on whether necessary conditions were met to kill a specified number of microorganisms for a given sterilization process, providing a level of confidence in the process.

Global Biological Indicators main players are 3M, Getinge Group, Cantel Medical, Mesa Laboratories, Steris, etc. Global top five manufacturers hold a share over 65%. North America is the largest market, with a share nearly 55%.

Report Includes

Read the full market overview

This report presents an overview of global market for Biological Indicators, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Biological Indicators, also provides the revenue of main regions and countries. Of the upcoming market potential for Biological Indicators, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biological Indicators revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Biological Indicators market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Biological Indicators revenue, projected growth trends, production technology, application and end-user industry.

Biological Indicators Segment by Company

3M

Getinge Group

Cantel Medical

Mesa Laboratories

Steris

Fuze Medical

Matachana

Hu-Friedy

Advanced Sterilization

Bag Health Care

Terragene

Andersen

GKE

Biological Indicators Segment by Type

Self-Contained Biological Indicator

Biological Indicator Strip

Biological Indicators Segment by Application

Hospital

Pharma Companies

Others

Biological Indicators Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biological Indicators market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biological Indicators and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biological Indicators.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Biological Indicators in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Biological Indicators company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Biological Indicators revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Biological Indicators Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Self-Contained Biological Indicator Major Player Table 3. Biological Indicator Strip Major Player Table 4. Global Biological Indicators Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Player Table 6. Pharma Companies Major Player Table 7. Others Major Player Table 8. Biological Indicators Industry Trends Table 9. Biological Indicators Industry Drivers Table 10. Biological Indicators Industry Opportunities and Challenges Table 11. Biological Indicators Industry Restraints Table 12. Global Biological Indicators Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 13. Global Biological Indicators Market Size by Region (2021-2026) & (US$ Million) Table 14. Global Biological Indicators Market Share by Region (2021-2026) Table 15. Global Biological Indicators Market Size by Region (2027-2032) & (US$ Million) Table 16. Global Biological Indicators Market Share by Region (2027-2032) Table 17. Global Biological Indicators Revenue by Players (US$ Million) & (2021-2026) Table 18. Global Biological Indicators Revenue Market Share by Players (2021-2026) Table 19. Global Biological Indicators Key Players Ranking, 2024 VS 2025 VS 2026 Table 20. Global Biological Indicators Key Players Headquarters & Area Served Table 21. Global Biological Indicators Players, Product Type & Application Table 22. Global Biological Indicators Players Establishment Date Table 23. Global Players Market Concentration Ratio (CR5 and HHI) Table 24. Global Biological Indicators by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 25. Global Biological Indicators Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Biological Indicators Revenue by Type (2021-2026) & (US$ Million) Table 27. Global Biological Indicators Revenue by Type (2027-2032) & (US$ Million) Table 28. Global Biological Indicators Revenue Market Share by Type (2021-2026) Table 29. Global Biological Indicators Revenue Market Share by Type (2027-2032) Table 30. Global Biological Indicators Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Biological Indicators Revenue by Application (2021-2026) & (US$ Million) Table 32. Global Biological Indicators Revenue by Application (2027-2032) & (US$ Million) Table 33. Global Biological Indicators Revenue Market Share by Application (2021-2026) Table 34. Global Biological Indicators Revenue Market Share by Application (2027-2032) Table 35. 3M Company Information Table 36. 3M Business Overview Table 37. 3M Biological Indicators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. 3M Biological Indicators Product Portfolio Table 39. 3M Recent Development Table 40. Getinge Group Company Information Table 41. Getinge Group Business Overview Table 42. Getinge Group Biological Indicators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Getinge Group Biological Indicators Product Portfolio Table 44. Getinge Group Recent Development Table 45. Cantel Medical Company Information Table 46. Cantel Medical Business Overview Table 47. Cantel Medical Biological Indicators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Cantel Medical Biological Indicators Product Portfolio Table 49. Cantel Medical Recent Development Table 50. Mesa Laboratories Company Information Table 51. Mesa Laboratories Business Overview Table 52. Mesa Laboratories Biological Indicators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Mesa Laboratories Biological Indicators Product Portfolio Table 54. Mesa Laboratories Recent Development Table 55. Steris Company Information Table 56. Steris Business Overview Table 57. Steris Biological Indicators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Steris Biological Indicators Product Portfolio Table 59. Steris Recent Development Table 60. Fuze Medical Company Information Table 61. Fuze Medical Business Overview Table 62. Fuze Medical Biological Indicators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Fuze Medical Biological Indicators Product Portfolio Table 64. Fuze Medical Recent Development Table 65. Matachana Company Information Table 66. Matachana Business Overview Table 67. Matachana Biological Indicators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Matachana Biological Indicators Product Portfolio Table 69. Matachana Recent Development Table 70. Hu-Friedy Company Information Table 71. Hu-Friedy Business Overview Table 72. Hu-Friedy Biological Indicators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Hu-Friedy Biological Indicators Product Portfolio Table 74. Hu-Friedy Recent Development Table 75. Advanced Sterilization Company Information Table 76. Advanced Sterilization Business Overview Table 77. Advanced Sterilization Biological Indicators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Advanced Sterilization Biological Indicators Product Portfolio Table 79. Advanced Sterilization Recent Development Table 80. Bag Health Care Company Information Table 81. Bag Health Care Business Overview Table 82. Bag Health Care Biological Indicators Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Bag Health Care Biological Indicators Product Portfolio Table 84. Bag Health Care Recent Development Table 85. Terragene Company Information Table 86. Terragene Business Overview Table 87. Terragene Biological Indicators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 88. Terragene Biological Indicators Product Portfolio Table 89. Terragene Recent Development Table 90. Andersen Company Information Table 91. Andersen Business Overview Table 92. Andersen Biological Indicators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 93. Andersen Biological Indicators Product Portfolio Table 94. Andersen Recent Development Table 95. GKE Company Information Table 96. GKE Business Overview Table 97. GKE Biological Indicators Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026) Table 98. GKE Biological Indicators Product Portfolio Table 99. GKE Recent Development Table 100. North America Biological Indicators Revenue by Type (2021-2026) & (US$ Million) Table 101. North America Biological Indicators Revenue by Type (2027-2032) & (US$ Million) Table 102. North America Biological Indicators Revenue by Application (2021-2026) & (US$ Million) Table 103. North America Biological Indicators Revenue by Application (2027-2032) & (US$ Million) Table 104. North America Biological Indicators Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Biological Indicators Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Biological Indicators Revenue by Country (US$ Million) & (2027-2032) Table 107. Europe Biological Indicators Revenue by Type (2021-2026) & (US$ Million) Table 108. Europe Biological Indicators Revenue by Type (2027-2032) & (US$ Million) Table 109. Europe Biological Indicators Revenue by Application (2021-2026) & (US$ Million) Table 110. Europe Biological Indicators Revenue by Application (2027-2032) & (US$ Million) Table 111. Europe Biological Indicators Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe Biological Indicators Revenue by Country (2021-2026) & (US$ Million) Table 113. Europe Biological Indicators Revenue by Country (US$ Million) & (2027-2032) Table 114. China Biological Indicators Revenue by Type (2021-2026) & (US$ Million) Table 115. China Biological Indicators Revenue by Type (2027-2032) & (US$ Million) Table 116. China Biological Indicators Revenue by Application (2021-2026) & (US$ Million) Table 117. China Biological Indicators Revenue by Application (2027-2032) & (US$ Million) Table 118. Asia Biological Indicators Revenue by Type (2021-2026) & (US$ Million) Table 119. Asia Biological Indicators Revenue by Type (2027-2032) & (US$ Million) Table 120. Asia Biological Indicators Revenue by Application (2021-2026) & (US$ Million) Table 121. Asia Biological Indicators Revenue by Application (2027-2032) & (US$ Million) Table 122. Asia Biological Indicators Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Asia Biological Indicators Revenue by Region (US$ Million) & (2021-2026) Table 124. Asia Biological Indicators Revenue by Region (US$ Million) & (2027-2032) Table 125. SAMEA Biological Indicators Revenue by Type (2021-2026) & (US$ Million) Table 126. SAMEA Biological Indicators Revenue by Type (2027-2032) & (US$ Million) Table 127. SAMEA Biological Indicators Revenue by Application (2021-2026) & (US$ Million) Table 128. SAMEA Biological Indicators Revenue by Application (2027-2032) & (US$ Million) Table 129. SAMEA Biological Indicators Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. SAMEA Biological Indicators Revenue by Country (2021-2026) & (US$ Million) Table 131. SAMEA Biological Indicators Revenue by Country (US$ Million) & (2027-2032) Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. Biological Indicators Image Figure 2. Global Biological Indicators Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Biological Indicators Market Size Share 2021 VS 2025 VS 2032 Figure 4. Self-Contained Biological Indicator Image Figure 5. Biological Indicator Strip Image Figure 6. Global Biological Indicators Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Biological Indicators Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Pharma Companies Image Figure 10. Others Image Figure 11. Global Biological Indicators Market Size (US$ Million) & (2021-2032) Figure 12. Global Biological Indicators Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Biological Indicators Market Share by Region: 2021 VS 2025 VS 2032 Figure 14. Global Biological Indicators Players Revenue Share Top 10 and Top 5 in 2025 Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 16. Global Biological Indicators Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Biological Indicators Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Biological Indicators Revenue Market Share by Type (2021-2032) Figure 19. Global Biological Indicators Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Biological Indicators Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 21. Global Biological Indicators Revenue Market Share by Application (2021-2032) Figure 22. North America Biological Indicators Revenue YoY Growth (2021-2032) & (US$ Million) Figure 23. North America Biological Indicators Revenue Share by Type (2021-2032) Figure 24. North America Biological Indicators Revenue Share by Application (2021-2032) Figure 25. North America Biological Indicators Revenue Share by Country (2021-2032) Figure 26. United States Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Canada Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Mexico Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Europe Biological Indicators Revenue YoY Growth (2021-2032) & (US$ Million) Figure 30. Europe Biological Indicators Revenue Share by Type (2021-2032) Figure 31. Europe Biological Indicators Revenue Share by Application (2021-2032) Figure 32. Europe Biological Indicators Revenue Share by Country (2021-2032) Figure 33. Germany Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. France Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. U.K. Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Italy Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Spain Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Russia Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Netherlands Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Nordic Countries Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. China Biological Indicators Revenue YoY Growth (2021-2032) & (US$ Million) Figure 42. China Biological Indicators Revenue Share by Type (2021-2032) Figure 43. China Biological Indicators Revenue Share by Application (2021-2032) Figure 44. Asia Biological Indicators Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. Asia Biological Indicators Revenue Share by Type (2021-2032) Figure 46. Asia Biological Indicators Revenue Share by Application (2021-2032) Figure 47. Asia Biological Indicators Revenue Share by Region (2021-2032) Figure 48. Japan Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. South Korea Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. India Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Australia Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Taiwan Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Southeast Asia Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. SAMEA Biological Indicators Revenue YoY Growth (2021-2032) & (US$ Million) Figure 55. SAMEA Biological Indicators Revenue Share by Type (2021-2032) Figure 56. SAMEA Biological Indicators Revenue Share by Application (2021-2032) Figure 57. SAMEA Biological Indicators Revenue Share by Country (2021-2032) Figure 58. Brazil Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Argentina Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Chile Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Colombia Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Peru Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Saudi Arabia Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Israel Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. UAE Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Turkey Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Iran Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Egypt Biological Indicators Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Self-Contained Biological Indicator
  • Biological Indicator Strip
Applications
  • Hospital
  • Pharma Companies
  • Others
Companies covered
  • 3M
  • Getinge Group
  • Cantel Medical
  • Mesa Laboratories
  • Steris
  • Fuze Medical
  • Matachana
  • Hu-Friedy
  • Advanced Sterilization
  • Bag Health Care
  • Terragene
  • Andersen
  • GKE

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Biological Indicators Market by Type
  3. 1.2.1 Global Biological Indicators Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Self-Contained Biological Indicator
  5. 1.2.3 Biological Indicator Strip
  6. 1.3 Biological Indicators Market by Application
  7. 1.3.1 Global Biological Indicators Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Pharma Companies
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Biological Indicators Market Dynamics
  1. 2.1 Biological Indicators Industry Trends
  2. 2.2 Biological Indicators Industry Drivers
  3. 2.3 Biological Indicators Industry Opportunities and Challenges
  4. 2.4 Biological Indicators Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Biological Indicators Market Perspective (2021-2032)
  2. 3.2 Global Biological Indicators Growth Trends by Region
  3. 3.2.1 Global Biological Indicators Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Biological Indicators Market Size by Region (2021-2026)
  5. 3.2.3 Global Biological Indicators Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Biological Indicators Revenue by Players
  2. 4.1.1 Global Biological Indicators Revenue by Players (2021-2026)
  3. 4.1.2 Global Biological Indicators Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Biological Indicators Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Biological Indicators Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Biological Indicators Key Players Headquarters & Area Served
  7. 4.4 Global Biological Indicators Players, Product Type & Application
  8. 4.5 Global Biological Indicators Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Biological Indicators Market CR5 and HHI
  11. 4.6.3 2025 Biological Indicators Tier 1, Tier 2, and Tier 3
5 Biological Indicators Market Size by Type
  1. 5.1 Global Biological Indicators Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Biological Indicators Revenue by Type (2021-2032)
  3. 5.3 Global Biological Indicators Revenue Market Share by Type (2021-2032)
6 Biological Indicators Market Size by Application
  1. 6.1 Global Biological Indicators Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Biological Indicators Revenue by Application (2021-2032)
  3. 6.3 Global Biological Indicators Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 3M
  2. 7.1.1 3M Company Information
  3. 7.1.2 3M Business Overview
  4. 7.1.3 3M Biological Indicators Revenue and Gross Margin (2021-2026)
  5. 7.1.4 3M Biological Indicators Product Portfolio
  6. 7.1.5 3M Recent Developments
  7. 7.2 Getinge Group
  8. 7.2.1 Getinge Group Company Information
  9. 7.2.2 Getinge Group Business Overview
  10. 7.2.3 Getinge Group Biological Indicators Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Getinge Group Biological Indicators Product Portfolio
  12. 7.2.5 Getinge Group Recent Developments
  13. 7.3 Cantel Medical
  14. 7.3.1 Cantel Medical Company Information
  15. 7.3.2 Cantel Medical Business Overview
  16. 7.3.3 Cantel Medical Biological Indicators Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Cantel Medical Biological Indicators Product Portfolio
  18. 7.3.5 Cantel Medical Recent Developments
  19. 7.4 Mesa Laboratories
  20. 7.4.1 Mesa Laboratories Company Information
  21. 7.4.2 Mesa Laboratories Business Overview
  22. 7.4.3 Mesa Laboratories Biological Indicators Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Mesa Laboratories Biological Indicators Product Portfolio
  24. 7.4.5 Mesa Laboratories Recent Developments
  25. 7.5 Steris
  26. 7.5.1 Steris Company Information
  27. 7.5.2 Steris Business Overview
  28. 7.5.3 Steris Biological Indicators Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Steris Biological Indicators Product Portfolio
  30. 7.5.5 Steris Recent Developments
  31. 7.6 Fuze Medical
  32. 7.6.1 Fuze Medical Company Information
  33. 7.6.2 Fuze Medical Business Overview
  34. 7.6.3 Fuze Medical Biological Indicators Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Fuze Medical Biological Indicators Product Portfolio
  36. 7.6.5 Fuze Medical Recent Developments
  37. 7.7 Matachana
  38. 7.7.1 Matachana Company Information
  39. 7.7.2 Matachana Business Overview
  40. 7.7.3 Matachana Biological Indicators Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Matachana Biological Indicators Product Portfolio
  42. 7.7.5 Matachana Recent Developments
  43. 7.8 Hu-Friedy
  44. 7.8.1 Hu-Friedy Company Information
  45. 7.8.2 Hu-Friedy Business Overview
  46. 7.8.3 Hu-Friedy Biological Indicators Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Hu-Friedy Biological Indicators Product Portfolio
  48. 7.8.5 Hu-Friedy Recent Developments
  49. 7.9 Advanced Sterilization
  50. 7.9.1 Advanced Sterilization Company Information
  51. 7.9.2 Advanced Sterilization Business Overview
  52. 7.9.3 Advanced Sterilization Biological Indicators Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Advanced Sterilization Biological Indicators Product Portfolio
  54. 7.9.5 Advanced Sterilization Recent Developments
  55. 7.10 Bag Health Care
  56. 7.10.1 Bag Health Care Company Information
  57. 7.10.2 Bag Health Care Business Overview
  58. 7.10.3 Bag Health Care Biological Indicators Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Bag Health Care Biological Indicators Product Portfolio
  60. 7.10.5 Bag Health Care Recent Developments
  61. 7.11 Terragene
  62. 7.11.1 Terragene Company Information
  63. 7.11.2 Terragene Business Overview
  64. 7.11.3 Terragene Biological Indicators Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Terragene Biological Indicators Product Portfolio
  66. 7.11.5 Terragene Recent Developments
  67. 7.12 Andersen
  68. 7.12.1 Andersen Company Information
  69. 7.12.2 Andersen Business Overview
  70. 7.12.3 Andersen Biological Indicators Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Andersen Biological Indicators Product Portfolio
  72. 7.12.5 Andersen Recent Developments
  73. 7.13 GKE
  74. 7.13.1 GKE Company Information
  75. 7.13.2 GKE Business Overview
  76. 7.13.3 GKE Biological Indicators Revenue and Gross Margin (2021-2026)
  77. 7.13.4 GKE Biological Indicators Product Portfolio
  78. 7.13.5 GKE Recent Developments
8 North America
  1. 8.1 North America Biological Indicators Revenue (2021-2032)
  2. 8.2 North America Biological Indicators Revenue by Type (2021-2032)
  3. 8.2.1 North America Biological Indicators Revenue by Type (2021-2026)
  4. 8.2.2 North America Biological Indicators Revenue by Type (2027-2032)
  5. 8.3 North America Biological Indicators Revenue Share by Type (2021-2032)
  6. 8.4 North America Biological Indicators Revenue by Application (2021-2032)
  7. 8.4.1 North America Biological Indicators Revenue by Application (2021-2026)
  8. 8.4.2 North America Biological Indicators Revenue by Application (2027-2032)
  9. 8.5 North America Biological Indicators Revenue Share by Application (2021-2032)
  10. 8.6 North America Biological Indicators Revenue by Country
  11. 8.6.1 North America Biological Indicators Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Biological Indicators Revenue by Country (2021-2026)
  13. 8.6.3 North America Biological Indicators Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Biological Indicators Revenue (2021-2032)
  2. 9.2 Europe Biological Indicators Revenue by Type (2021-2032)
  3. 9.2.1 Europe Biological Indicators Revenue by Type (2021-2026)
  4. 9.2.2 Europe Biological Indicators Revenue by Type (2027-2032)
  5. 9.3 Europe Biological Indicators Revenue Share by Type (2021-2032)
  6. 9.4 Europe Biological Indicators Revenue by Application (2021-2032)
  7. 9.4.1 Europe Biological Indicators Revenue by Application (2021-2026)
  8. 9.4.2 Europe Biological Indicators Revenue by Application (2027-2032)
  9. 9.5 Europe Biological Indicators Revenue Share by Application (2021-2032)
  10. 9.6 Europe Biological Indicators Revenue by Country
  11. 9.6.1 Europe Biological Indicators Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Biological Indicators Revenue by Country (2021-2026)
  13. 9.6.3 Europe Biological Indicators Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Biological Indicators Revenue (2021-2032)
  2. 10.2 China Biological Indicators Revenue by Type (2021-2032)
  3. 10.2.1 China Biological Indicators Revenue by Type (2021-2026)
  4. 10.2.2 China Biological Indicators Revenue by Type (2027-2032)
  5. 10.3 China Biological Indicators Revenue Share by Type (2021-2032)
  6. 10.4 China Biological Indicators Revenue by Application (2021-2032)
  7. 10.4.1 China Biological Indicators Revenue by Application (2021-2026)
  8. 10.4.2 China Biological Indicators Revenue by Application (2027-2032)
  9. 10.5 China Biological Indicators Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Biological Indicators Revenue (2021-2032)
  2. 11.2 Asia Biological Indicators Revenue by Type (2021-2032)
  3. 11.2.1 Asia Biological Indicators Revenue by Type (2021-2026)
  4. 11.2.2 Asia Biological Indicators Revenue by Type (2027-2032)
  5. 11.3 Asia Biological Indicators Revenue Share by Type (2021-2032)
  6. 11.4 Asia Biological Indicators Revenue by Application (2021-2032)
  7. 11.4.1 Asia Biological Indicators Revenue by Application (2021-2026)
  8. 11.4.2 Asia Biological Indicators Revenue by Application (2027-2032)
  9. 11.5 Asia Biological Indicators Revenue Share by Application (2021-2032)
  10. 11.6 Asia Biological Indicators Revenue by Country
  11. 11.6.1 Asia Biological Indicators Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Biological Indicators Revenue by Country (2021-2026)
  13. 11.6.3 Asia Biological Indicators Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Biological Indicators Revenue (2021-2032)
  2. 12.2 SAMEA Biological Indicators Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Biological Indicators Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Biological Indicators Revenue by Type (2027-2032)
  5. 12.3 SAMEA Biological Indicators Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Biological Indicators Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Biological Indicators Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Biological Indicators Revenue by Application (2027-2032)
  9. 12.5 SAMEA Biological Indicators Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Biological Indicators Revenue by Country
  11. 12.6.1 SAMEA Biological Indicators Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Biological Indicators Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Biological Indicators Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst